Precigen, Inc., originally known as Intrexon Corporation, is a biopharmaceutical company based in Germantown, Maryland, focusing on developing gene and cell therapies. With a foundation laid in 1998, Precigen advances treatments for a variety of diseases, including those in immuno-oncology, autoimmune disorders, and infectious diseases. The company's innovative precision technology propels its pipeline of preclinical and clinical therapies towards commercialization, aiming to revolutionize biotherapeutic solutions.

PGEN Articles